Abstract
The use and popularity of herbal medicines has been increasing worldwide. In fact, today, the traditional Chinese medicine offers a vast repertory for pharmaceutical research, as is the case of Huperzia serrata, a member of Huperziaceae family. This review reports the Lycopodium alkaloids that have been isolated from this plant. However, it was mainly focused on the huperzine A (HupA), a promising therapeutic option in several acute and chronic disorders. The major therapeutic interest described for HupA has been directed to the treatment of acetylcholine-deficit dementia, including Alzheimer’s disease. However, HupA was also shown to be effective on cerebrovascular dementia and other neurodegenerative disorders with an ischemic component, as well as on other kind of cognitive impairments; the value of HupA on myasthenia gravis, organophosphate poisoning and schizophrenia has also been described. In addition, many other pharmacological properties have been ascribed to HupA, namely its anti-inflammatory, antinociceptive and anticonvulsant properties, which was recently identified, promoting a growing interest on HupA research. Furthermore, its particular chemical structure and the fact that HupA is well tolerated in humans, even at doses well above those clinically required, along with its favorable pharmacokinetics, also boosted an intense research in the pharmaceutical industry. Therefore, several HupA-related features are addressed in this review, including not only its therapeutic properties, but also its chemistry, biological and chemical sources, structure–activity relationship, pharmacokinetics and toxicology, which are discussed in detail covering the literature published from 1962 to 2014.
Similar content being viewed by others
Abbreviations
- ACh:
-
Acetylcholine
- AChE:
-
Acetylcholinesterase
- AD:
-
Alzheimer’s disease
- bid:
-
Twice-daily
- BuChE:
-
Butyrylcholinesterase
- C max :
-
Peak concentration
- CNS:
-
Central nervous system
- CYP:
-
Cytochrome P450
- HupA:
-
Huperzine A
- im:
-
Intramuscular
- ip:
-
Intraperitoneal
- iv:
-
Intravenous
- LD50 :
-
Median lethal dose
- NMDA:
-
N-Methyl-d-aspartate
- po :
-
Per os
- sc:
-
Subcutaneous
References
Alcalá M, Vivas NM, Hospital S et al (2003) Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids. Neuropharmacology 44:749–755
Alves RRN, Alves HN (2011) The faunal drugstore: animal-based remedies used in traditional medicines in Latin America. J Ethnobiol Ethnomed 7:9
Andersen RA, Aaraas I, Gaare G, Fonnum F (1977) Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonylfluoride. Gen Pharmacol 8:331–334
Ashani Y, Peggins JO, Doctor BP (1992) Mechanism of inhibition of cholinesterases by huperzine A. Biochem Biophys Res Commun 184:719–726
Ayer WA, Berezowsky JA, Iverach GG (1962) Lycopodium alkaloids-II. Tetrahedron 18:567–573
Ayer WA, Ma Y-T, Liu J-S et al (1994) Macleanine, a unique type of dinitrogenous Lycopodium alkaloid. Can J Chem 72:128–130
Bai D (2007) Development of huperzine A and B for treatment of Alzheimer’s disease. Pure Appl Chem 79:469–479
Bai DL, Tang XC, He XC (2000) Huperzine A, a potential therapeutic agent for treatment of Alzheimer’s disease. Curr Med Chem 7:355–374
Bialer M, Johannessen SI, Kupferberg HJ et al (2007) Progress report on new antiepileptic drugs: a summary of the eighth Eilat conference (EILAT VIII). Epilepsy Res 73:1–52
Bialer M, Johannessen SI, Levy RH et al (2009) Progress report on new antiepileptic drugs: a summary of the ninth Eilat conference (EILAT IX). Epilepsy Res 83:1–43
Bialer M, Johannessen SI, Levy RH et al (2010) Progress report on new antiepileptic drugs: a summary of the tenth Eilat conference (EILAT X). Epilepsy Res 92:89–124
Boudinot E, Taysse L, Daulon S et al (2005) Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase. Pharmacol Biochem Behav 80:53–61
Brunhofer G, Fallarero A, Karlsson D et al (2012) Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorg Med Chem 20:6669–6679
Cadieux CL, Broomfield CA, Kirkpatrick MG et al (2010) Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation. Chem Biol Interact 187:229–233
Camps P, El Achab R, Morral J et al (2000) New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer’s disease. J Med Chem 43:4657–4666
Capurro V, Busquet P, Lopes JP et al (2013) Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer’s disease. PLoS ONE 8:e56870
Chang J (2000) Medicinal herbs: drugs or dietary supplements? Biochem Pharmacol 59:211–219
Cheng DH, Tang XC (1998) Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities. Pharmacol Biochem Behav 60:377–386
Cheng DH, Ren H, Tang XC (1996) Huperzine A, a novel promising acetylcholinesterase inhibitor. NeuroReport 8:97–101
Chu D-F, Fu X-Q, Liu W-H et al (2006) Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 325:116–123
Chu D, Tian J, Liu W et al (2007) Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chem Pharm Bull 55:625–628
Coleman BR, Ratcliffe RH, Oguntayo SA et al (2008) [+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure/status epilepticus in rats. Chem-Biol Interact 175:387–395
Ding R, Sun B-F, Lin G-Q (2012) An efficient total synthesis of (−)-huperzine A. Org Lett 14:4446–4449
Ding R, Fu J-G, Xu G-Q et al (2014) Divergent total synthesis of the Lycopodium alkaloids huperzine A, huperzine B, and huperzine U. J Org Chem 79:240–250
Dvir H, Jiang HL, Wong DM et al (2002) X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (−)-huperzine B: structural evidence for an active site rearrangement. Biochemistry 41:10810–10818
Eisenberg DM, Harris ESJ, Littlefield BA et al (2011) Develo** a library of authenticated Traditional Chinese Medicinal (TCM) plants for systematic biological evaluation—rationale, methods and preliminary results from a Sino-American collaboration. Fitoterapia 82:17–33
FDA (1999) Memorandum. In: http://www.fda.gov/ohrms/dockets/dailys/00/jan00/010300/rpt0055.pdf. Cited 10 Set 2014
Filliat P, Foquin A, Lallement G (2002) Effects of chronic administration of huperzine A on memory in guinea pigs. Drug Chem Toxicol 25:9–24
Gao X, Tang XC (2006) Huperzine A attenuates mitochondrial dysfunction in beta-amyloid-treated PC12 cells by reducing oxygen free radicals accumulation and improving mitochondrial energy metabolism. J Neurosci Res 83:1048–1057
Gao WY, Li YM, De Wang B, Zhu DY (1999) Huperzine H, a new Lycopodium alkaloid from Huperzia serrata. Chin Chem Lett 10:463–466
Gao W, Li Y, Jiang S, Zhu D (2000a) Three Lycopodium alkaloid N-oxides from Huperzia serrata. Planta Med 66:664–667
Gao Y, Tang XC, Guan LC, Kuang PZ (2000b) Huperzine A reverses scopolamine- and muscimol-induced memory deficits in chick. Acta Pharmacol Sin 21:1169–1173
Gao X, Zheng CY, Yang L et al (2009) Huperzine A protects isolated rat brain mitochondria against beta-amyloid peptide. Free Radic Biol Med 46:1454–1462
Gao W-Y, Wang B-D, Li Y-M et al (2010) A new alkaloid and arbutin from the whole plant of Huperzia serrata. Chin J Chem 18:614–616
Garcia GE, Hicks RP, Skanchy D et al (2004) Identification and characterization of the major huperzine a metabolite in rat blood. J Anal Toxicol 28:379–383
García-Ayllón M-S, Riba-Llena I, Serra-Basante C et al (2010) Altered levels of acetylcholinesterase in Alzheimer plasma. PLoS ONE 5:e8701
Gemma S, Gabellieri E, Huleatt P et al (2006) Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites. J Med Chem 49:3421–3425
Gordon RK, Nigam SV, Weitz JA et al (2001) The NMDA receptor ion channel: a site for binding of Huperzine A. J Anal Toxicol 21(Suppl 1):S47–S51
Grunwald J, Raveh L, Doctor BP, Ashani Y (1994) Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 54:991–997
Ha GT, Wong RK, Zhang Y (2011) Huperzine a as potential treatment of Alzheimer’s disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodivers 8:1189–1204
Hallak M, Giacobini E (1989) Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology 28:199–206
Hanin I, Tang XC, Kindel GL, Kozikowski AP (1993) Natural and synthetic Huperzine A: effect on cholinergic function in vitro and in vivo. Ann N Y Acad Sci 695:304–306
Haudrechy A, Chassaing C, Riche C, Langlois Y (2000) A formal synthesis of (+)-huperzine A. Tetrahedron 56:3181–3187
Holub J (1985) Transfers of Lycopodium species to Huperzia: with a note on generic classification in Huperziaceae. Folia Geobot Phytotaxon 20:67–80
Howes M-JR, Houghton PJ (2003) Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75:513–527
Hu P, Cross ML, Yuan SQ et al (1992) Mass spectrometric differentiation of huperzinine, N,N-dimethylhuperzine A and N-methylhuperzine B. Org Mass Spectrom 27:99–104
Huang J, He C (2010) Population structure and genetic diversity of Huperzia serrata (Huperziaceae) based on amplified fragment length polymorphism (AFLP) markers. Biochem Syst Ecol 38:1137–1147
Huang X-T, Qian Z-M, He X et al (2013) Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer’s disease. Neurobiol Aging 35:1045–1054
Inubushi Y, Ishii H, Yasui B et al (1967) Studies on the constituents of domestic Lycopodium plants. VII. Alkaloid constituents of Lycopodium serratum Thunb. var. serratum form. serratum (= Lycopodium serratum Thunb. var. Thunbergii Makino) and Lycopodium serratum Thunb. var. serratum form. inter. Yakugaku Zasshi 87:1394–1403
Ji S-G, Huo K-K, Wang J, Pan S-L (2008) A molecular phylogenetic study of Huperziaceae based on chloroplast rbcL and psbA-trnH sequences. J Syst Evol 46:213–219
Jia J-Y, Zhao Q-H, Liu Y et al (2013) Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer’s disease. Acta Pharmacol Sin 34:976–982
Jiang J, Liu Y, Min K et al (2010) Two New Lycopodine Alkaloids from Huperzia serrata. Helv Chim Acta 93:1187–1191
Jordá EG, Verdaguer E, Jiménez A et al (2004) (±)-huprine Y, (−)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration. J Alzheimers Dis 6:577–583
Katakawa K, Nozoe A, Kogure N et al (2007) Fawcettimine-related alkaloids from Lycopodium serratum. J Nat Prod 70:1024–1028
Kitajima M, Takayama H (2012) Lycopodium alkaloids: isolation and asymmetric synthesis. Top Curr Chem 309:1–31
Kolgazi M, Uslu U, Yuksel M et al (2013) The role of cholinergic anti-inflammatory pathway in acetic acid-induced colonic inflammation in the rat. Chem Biol Interact 205:72–80
Konrath EL, Neves BM, Passos CDS et al (2012) Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain. Phytomedicine 19:1321–1324
Kozikowski AP, Tückmantel W (1999) Chemistry, pharmacology, and clinical efficacy of the chinese nootropic agent huperzine A. Acc Chem Res 32:641–650
Laganière S, Corey J, Tang XC et al (1991) Acute and chronic studies with the anticholinesterase huperzine A: effect on central nervous system cholinergic parameters. Neuropharmacology 30:763–768
Lallement G, Veyret J, Masqueliez C et al (1997) Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol 11:387–394
Lallement G, Baille V, Baubichon D et al (2002) Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 23:1–5
Li YX, Zhang RQ, Li CR, Jiang XH (2007) Pharmacokinetics of huperzine A following oral administration to human volunteers. Eur J Drug Metab Pharmacokinet 32:183–187
Liang YQ, Tang XC (2004) Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats. Neurosci Lett 361:56–59
Liang Y, Tang X (2006) Comparative studies of huperzine A, donepezil, and rivastigmine on brain acetylcholine, dopamine, norepinephrine, and 5-hydroxytryptamine levels in freely-moving rats. Acta Pharmacol Sin 27:1127–1136
Liang YQ, Huang XT, Tang XC (2008) Huperzine A reverses cholinergic and monoaminergic dysfunction induced by bilateral nucleus basalis magnocellularis injection of beta-amyloid peptide (1–40) in rats. Cell Mol Neurobiol 28:87–101
Lin L-J, Lin L-Z, Cordell GA et al (1993) NMR assignments of huperzine a, serratinine and lucidioline. Phytochemistry 34:1425–1428
Little JT, Walsh S, Aisen PS (2008) An update on huperzine A as a treatment for Alzheimer’s disease. Expert Opin Invest Drugs 17:209–215
Liu JS, Yu CM, Zhou YZ et al (1986) Study on the chemistry of huperzine-A and huperzine-B. Acta Chim Sin 44:1035–1040
Liu HQ, Tan CH, Jiang SH, Zhu DY (2004) Huperzine V, a new Lycopodium alkaloid from Huperzia serrata. Chin Chem Lett 15:303–304
Liu L, **e G, Wang J, Sun J (2006) Experimental study on protective effects of HupA in the treatment of isocarbophos poisoning. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 24:323–325
Liu L, Wang J, **e G, Sun J (2013) Effect of huperzine A on neural lesion of acute organophosphate poisoning in mice. Wei Sheng Yan Jiu 42:419–423
Lu WH, Shou J, Tang XC (1988) Improving effect of huperzine A on discrimination performance in aged rats and adult rats with experimental cognitive impairment. Acta Pharmacol Sinica 9:11–15
Lu J-J, Pan W, Hu Y-J, Wang Y-T (2012) Multi-target drugs: the trend of drug research and development. PLoS ONE 7:e40262
Lucey C, Kelly SA, Mann J (2007) A concise and convergent (formal) total synthesis of huperzine A. Org Biomol Chem 5:301–306
Lunardi P, Nardin P, Guerra MC et al (2013) Huperzine A, but not tacrine, stimulates S100B secretion in astrocyte cultures. Life Sci 92:701–707
Luo H, Li Y, Sun C et al (2010) Comparison of 454-ESTs from Huperzia serrata and Phlegmariurus carinatus reveals putative genes involved in Lycopodium alkaloid biosynthesis and developmental regulation. BMC Plant Biol 10:209
Ma X, Gang DR (2004) The Lycopodium alkaloids. Nat Prod Rep 21:752–772
Ma X, Gang DR (2008) In vitro production of huperzine A, a promising drug candidate for Alzheimer’s disease. Phytochemistry 69:2022–2028
Ma X-Q, Jiang S-H, Zhu D-Y (1998) Alkaloid patterns in Huperzia and some related genera of Lycopodiaceae Sensu Lato occurring in China and their contribution to classification. Biochem Syst Ecol 26:723–728
Ma X, Wang H, **n J et al (2003a) Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of huperzine A. Eur J Pharmacol 461:89–92
Ma X-C, Wang H-X, **n J et al (2003b) Effects of huperzine A on liver cytochrome P-450 in rats. Acta Pharmacol Sin 24:831–835
Ma X-C, **n J, Wang H-X et al (2003c) Acute effects of huperzine A and tacrine on rat liver. Acta Pharmacol Sin 24:247–250
Ma X, Tan C, Zhu D, Gang DR (2005) Is there a better source of huperzine A than Huperzia serrata? Huperzine A content of Huperziaceae species in China. J Agric Food Chem 53:1393–1398
Ma X, Tan C, Zhu D, Gang DR (2006) A survey of potential huperzine A natural resources in China: the Huperziaceae. J Ethnopharmacol 104:54–67
Ma X, Tan C, Zhu D et al (2007) Huperzine A from Huperzia species-an ethnopharmacolgical review. J Ethnopharmacol 113:15–34
Ma T, Gong K, Yan Y et al (2013) Huperzine A promotes hippocampal neurogenesis in vitro and in vivo. Brain Res 1506:35–43
Malkova L, Kozikowski AP, Gale K (2011) The effects of huperzine A and IDRA 21 on visual recognition memory in young macaques. Neuropharmacology 60:1262–1268
Miao ZC, Yang ZS, Feng R (1989) The structure determination of a new alkaloid phlegmariuine-N by long-range two-dimensional and NOE difference NMR spectroscopy. Acta Pharmacol Sin 24:114–117
Morita H, Arisaka M, Yoshida N, Kobayashi J (2000) Serratezomines A-C, new alkaloids from Lycopodium serratum var. serratum. J Org Chem 65:6241–6245
Mukherjee PK, Kumar V, Mal M, Houghton PJ (2007) Acetylcholinesterase inhibitors from plants. Phytomedicine 14:289–300
Ortega MG, Vallejo MG, Cabrera JL et al (2006) Huperzia saururus, activity on synaptic transmission in the hippocampus. J Ethnopharmacol 104:374–378
Ou LY, Tang XC, Cai JX (2001) Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys. Eur J Pharmacol 433:151–156
Pang YP, Kozikowski AP (1994) Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies. J Comput Mol Des 8:669–681
Park P, Schachter S, Yaksh T (2010) Intrathecal huperzine A increases thermal escape latency and decreases flinching behavior in the formalin test in rats. Neurosci Lett 470:6–9
Patocka J (1998) Huperzine A—an interesting anticholinesterase compound from the Chinese herbal medicine. Acta Med (Hradec Králové) 41:155–157
Pauliková I, Hrabovská A, Helia O, Devínsky F (2006) Inter-tissue and inter-species comparison of butyrylcholinesterases. Biologia (Bratisl) 61:709–712
Pep** J (2000) Huperzine A. Am J Heal Pharm 57:530–534
Perry E, Howes M-JR (2011) Medicinal plants and dementia therapy: herbal hopes for brain aging? CNS Neurosci Ther 17:683–698
Pibiri F, Kozikowski AP, Pinna G et al (2008) The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice. Proc Natl Acad Sci U S A 105:14169–14174
Pohanka M, Zemek F, Bandouchova H, Pikula J (2012) Toxicological scoring of Alzheimer’s disease drug huperzine in a guinea pig model. Toxicol Mech Methods 22:231–235
Prati F, Uliassi E, Bolognesi ML (2014) Two diseases, one approach: multitarget drug discovery in Alzheimer’s and neglected tropical diseases. Med Chem Commun 5:853–861
Qian L, Ji R (1989) A total synthesis of (±)-huperzine A. Tetrahedron Lett 30:2089–2090
Qian BC, Wang M, Zhou ZF et al (1995) Pharmacokinetics of tablet huperzine A in six volunteers. Acta Pharmacol Sin 16:396–398
Rafii MS, Walsh S, Little JT et al (2011) A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology 76:1389–1394
Raves ML, Harel M, Pang YP et al (1997) Structure of acetylcholinesterase complexed with the nootropic alkaloid, (−)-huperzine A. Nat Struct Biol 4:57–63
Reynolds IJ, Miller RJ (1988) Multiple sites for the regulation of the N-methyl-D-aspartate receptor. Mol Pharmacol 33:581–584
Ros E, Aleu J, Gómez de Aranda I et al (2001) The pharmacology of novel acetylcholinesterase inhibitors, (±)-huprines Y and X, on the Torpedo electric organ. Eur J Pharmacol 421:77–84
Rothmaler W (2008) Pteridophyten-Studien I. Reper Spec Nov Regni Veg 54:55–82
Ruan Q, Liu F, Gao Z et al (2013) The anti-inflamm-aging and hepatoprotective effects of huperzine A in d-galactose-treated rats. Mech Ageing Dev 134:89–97
Rudakova EV, Boltneva NP, Makhaeva GF (2011) Comparative analysis of esterase activities of human, mouse, and rat blood. Bull Exp Biol Med 152:73–75
Saxena A, Qian N, Kovach IM et al (1994) Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases. Protein Sci 3:1770–1778
Schachter SC (2009) Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics 6:415–420
Schneider BM, Dodman NH, Faissler D, Ogata N (2009) Clinical use of an herbal-derived compound (Huperzine A) to treat putative complex partial seizures in a dog. Epilepsy Behav 15:529–534
Shang YZ, Ye JW, Tang XC (1999) Improving effects of huperzine A on abnormal lipid peroxidation and superoxide dismutase in aged rats. Acta Pharmacol Sin 20:824–828
Sharma VK (2010) Herbal help in Alzheimer’s type of cognitive disorders : a comprehensive review. Drug Invent Today 2:320–324
Shi Q, Fu J, Ge D et al (2012) Huperzine A ameliorates cognitive deficits and oxidative stress in the hippocampus of rats exposed to acute hypobaric hypoxia. Neurochem Res 37:2042–2052
Skolnick AA (1997) Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy. JAMA 277:776
Sui X, Gao C (2014) Huperzine A ameliorates damage induced by acute myocardial infarction in rats through antioxidant, anti-apoptotic and anti-inflammatory mechanisms. Int J Mol Med 33:227–233
Sun QQ, Xu SS, Pan JL et al (1999) Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Acta Pharmacol Sin 20:601–603
Sussman JL, Harel M, Frolow F et al (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253:872–879
Szypuła WJ, Mistrzak P, Olszowska O (2013) A new and fast method to obtain in vitro cultures of Huperzia selago (Huperziaceae) sporophytes, a club moss which is a source of huperzine A. Acta Soc Bot Pol 82:313–320
Takayama H, Katakawa K, Kitajima M et al (2001) A new type of Lycopodium alkaloid, lycoposerramine-A, from Lycopodium serratum Thunb. Org Lett 3:4165–4167
Takayama H, Katakawa K, Kitajima M et al (2003) Ten new Lycopodium alkaloids having the lycopodane skeleton isolated from Lycopodium serratum Thunb. Chem Pharm Bull 51:1163–1169
Tan C-H, Zhu D-Y (2004) Lycopodine-type Lycopodium alkaloids from Huperzia serrata. Helv Chim Acta 87:1963–1967
Tan C-H, Jiang S-H, Zhu D-Y (2000a) Huperzine P, a novel Lycopodium alkaloid from Huperzia serrata. Tetrahedron Lett 41:5733–5736
Tan X-J, Wang H-Q, Jiang H-L et al (2000b) Structure assignment of 8 alpha-OH phlegmariurine B—a combined NMR and density functional theory investigation. Tetrahedron Lett 58:1386–1392
Tan C-H, Chen G-F, Ma X-Q et al (2002a) Huperzine R, a novel 15-carbon Lycopodium alkaloid from Huperzia serrata. J Nat Prod 65:1021–1022
Tan C-H, Chen G-F, Ma X-Q et al (2002b) Three new phlegmariurine B type Lycopodium alkaloids from Huperzia serrata. J Asian Nat Prod Res 4:227–231
Tan C-H, Ma X-Q, Chen G-F et al (2002c) Huperzine W, a novel 14 carbons Lycopodium alkaloid from Huperzia serrata. Chin Chem Lett 13:331–332
Tan C-H, Ma X-Q, Chen G-F, Zhu D-Y (2002d) Two novel Lycopodium alkaloids from Huperzia serrata. Helv Chim Acta 85:1058–1061
Tan C-H, Ma X-Q, Jiang S-H, Zhu D-Y (2002e) Three new hydroxylated serratidine alkaloids from Huperzia serrata. Nat Prod Lett 16:149–153
Tan C-H, Ma X-Q, Chen G-F, Zhu D-Y (2003a) Huperzines S, T, and U: new Lycopodium alkaloids from Huperzia serrata. Can J Chem 318:315–318
Tan C-H, Ma X-Q, Zhou H et al (2003b) Two novel hydroperoxylated Lycopodium alkaloids from Huperzia serrata. Acta Bot Sin 45:118–121
Tang XC, Han YF (1999) Pharmacological profile of huperzine A, a novel acetylcholinesterase inhibitor from Chinese herb. CNS Drug Rev 5:281–300
Tang XC, Han YF, Chen XP, Zhu XD (1986) Effects of huperzine A on learning and retrieval process of discrimination performance in rats. Acta Pharmacol Sinica 7:507–511
Tang XC, De Sarno P, Sugaya K, Giacobini E (1989) Effect of huperzine A, a new cholinesterase inhibitor, on the central cholinergic system of the rat. J Neurosci Res 24:276–285
Tang XC, Kindel GH, Kozikowski AP, Hanin I (1994) Comparison of the effects of natural and synthetic huperzine-A on rat brain cholinergic function in vitro and in vivo. J Ethnopharmacol 44:147–155
Tang L-L, Wang R, Tang X-C (2005a) Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells. Acta Pharmacol Sin 26:673–678
Tang L-L, Wang R, Tang X-C (2005b) Huperzine A protects SHSY5Y neuroblastoma cells against oxidative stress damage via nerve growth factor production. Eur J Pharmacol 519:9–15
The Plant List. In: www.theplantlist.org. Cited 10 Sept 2014
Tonduli LS, Testylier G, Masqueliez C et al (2001) Effects of Huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology 22:29–37
Toribio A, Delannay E, Richard B et al (2007) Preparative isolation of huperzines A and B from Huperzia serrata by displacement centrifugal partition chromatography. J Chromatogr A 1140:101–106
Tun MKM, Wüstmann D-J, Herzon SB (2011) A robust and scalable synthesis of the potent neuroprotective agent (−)-huperzine A. Chem Sci 2:2251
Tyagi A, Delanty N (2003) Herbal remedies, dietary supplements, and seizures. Epilepsia 44:228–235
Vallejo MG, Ortega MG, Cabrera JL et al (2007) Huperzia saururus increases memory retention in rats. J Ethnopharmacol 111:685–687
Vallejo MG, Ortega MG, Cabrera JL et al (2009) Sauroine, an alkaloid from Huperzia saururus with activity in wistar rats in electrophysiological and behavioral assays related to memory retention. J Nat Prod 72:156–158
Ved HS, Koenig ML, Dave JR, Doctor BP (1997) Huperzine A, a potential therapeutic agent for dementia, reduces neuronal cell death caused by glutamate. NeuroReport 8:963–968
Wang H, Tang XC (1998a) Anticholinesterase effects of huperzine A, E2020, and tacrine in rats. Acta Pharmacol Sin 19:27–30
Wang T, Tang XC (1998b) Reversal of scopolamine-induced deficits in radial maze performance by (−)-huperzine A: comparison with E2020 and tacrine. Eur J Pharmacol 349:137–142
Wang R, Tang XC (2005) Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease. Neurosignals 14:71–82
Wang ZF, Tang XC (2007) Huperzine A protects C6 rat glioma cells against oxygen–glucose deprivation-induced injury. FEBS Lett 581:596–602
Wang YE, Feng J, Lu WH, Tang XC (1988) Pharmacokinetics of huperzine A in rats and mice. Acta Pharmacol Sin 9:193–196
Wang B-D, Jiang S-H, Gao W-Y et al (1998) Structural identification of huperzine O. Acta Chim Sin 40:842–845
Wang XD, Zhang JM, Yang HH, Hu GY (1999) Modulation of NMDA receptor by huperzine A in rat cerebral cortex. Acta Pharmacol Sin 20:31–35
Wang LM, Han YF, Tang XC (2000) Huperzine A improves cognitive deficits caused by chronic cerebral hypoperfusion in rats. Eur J Pharmacol 398:65–72
Wang R, Zhang HY, Tang XC (2001) Huperzine A attenuates cognitive dysfunction and neuronal degeneration caused by beta-amyloid protein-(1–40) in rat. Eur J Pharmacol 421:149–156
Wang LS, Zhou J, Shao XM, Tang XC (2002a) Huperzine A attenuates cognitive deficits and brain injury in neonatal rats after hypoxia-ischemia. Brain Res 949:162–170
Wang Z-F, Zhou J, Tang X-C (2002b) Huperzine B protects rat pheochromocytoma cells against oxygen–glucose deprivation-induced injury. Acta Pharmacol Sin 23:1193–1198
Wang L, Zhou J, Shao X, Tang X (2003) Huperzine A attenuates cognitive deficits and brain injury after hypoxia-ischemic brain damage in neonatal rats. Zhonghua er ke za zhi 41:42–45
Wang Y, Chu D, Gu J et al (2004) Liquid chromatographic-tandem mass spectrometric method for the quantitation of huperzine A in dog plasma. J Chromatogr B 803:375–378
Wang G, Zhang S, Zhan H (2006a) Effect of huperzine A on cerebral cholinesterase and acetylcholine in elderly patients during recovery from general anesthesia. Nan Fang Yi Ke Da Xue Xue Bao 26:1660–1662
Wang R, Yan H, Tang X (2006b) Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine. Acta Pharmacol Sin 27:1–26
Wang Z, Tang L, Yan H et al (2006c) Effects of huperzine A on memory deficits and neurotrophic factors production after transient cerebral ischemia and reperfusion in mice. Pharmacol Biochem Behav 83:603–611
Wang H-B, Tan C-H, Tan J-J et al (2007) Lycopodium alkaloids from Huperzia serrata. Helv Chim Acta 90:153–157
Wang Z-F, Wang J, Zhang H-Y, Tang X-C (2008) Huperzine A exhibits anti-inflammatory and neuroprotective effects in a rat model of transient focal cerebral ischemia. J Neurochem 106:1594–1603
Wang B-S, Wang H, Wei Z-H et al (2009a) Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer’s disease: an updated meta-analysis. J Neural Transm 116:457–465
Wang H-B, Tan C-H, Tan J-J et al (2009b) Two new N-oxide Lycopodium alkaloids from Huperzia serrata. Nat Prod Res 23:1363–1366
Wang J, Zhang HY, Tang XC (2010) Huperzine a improves chronic inflammation and cognitive decline in rats with cerebral hypoperfusion. J Neurosci Res 88:807–815
Wang C-Y, Zheng W, Wang T et al (2011a) Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse model. Neuropsychopharmacology 36:1073–1089
Wang Y, Wei Y, Oguntayo S et al (2011b) [+]-Huperzine A protects against soman toxicity in guinea pigs. Neurochem Res 36:2381–2390
Wang Y, Tang XC, Zhang HY (2012) Huperzine A alleviates synaptic deficits and modulates amyloidogenic and nonamyloidogenic pathways in APPswe/PS1dE9 transgenic mice. J Neurosci Res 90:508–517
Wang Y, Wei Y, Oguntayo S et al (2013) A combination of [+] and [−]-huperzine A improves protection against soman toxicity compared to [+]-huperzine A in guinea pigs. Chem-Biol Interact 203:120–124
White JD, Li Y, Kim J, Terinek M (2013) A novel synthesis of (−)-huperzine A via tandem intramolecular aza-Prins cyclization-cyclobutane fragmentation. Org Lett 15:882–885
Woods S (2013) Huperzine for Cognitive and functional impairment in schizophrenia (NCT00963846). In: Clin. Web site. http://clinicaltrials.gov/ct2/show/NCT00963846?term=huperzine+and+Schizophrenia&rank=1. Cited 17 Jun 2013
Wu Q, Gu Y (2006) Quantification of huperzine A in Huperzia serrata by HPLC-UV and identification of the major constituents in its alkaloid extracts by HPLC-DAD-MS-MS. J Pharm Biomed Anal 40:993–998
Wu T-Y, Chen C-P, Chen C-P, **n T-R (2011) Traditional Chinese medicines and Alzheimer’s disease. Taiwan J Obs Gynecol 50:131–135
**a Y, Kozikowski AP (1989) A practical synthesis of the Chinese “nootropic” agent huperzine A: a possible lead in the treatment of Alzheimer’s disease. J Am Chem Soc 111:4116–4117
**ao XQ, Yang JW, Tang XC (1999) Huperzine A protects rat pheochromocytoma cells against hydrogen peroxide-induced injury. Neurosci Lett 275:73–76
**ao XQ, Wang R, Han YF, Tang XC (2000a) Protective effects of huperzine A on β-amyloid25–35 induced oxidative injury in rat pheochromocytoma cells. Neurosci Lett 286:155–158
**ao XQ, Wang R, Tang XC (2000b) Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury. J Neurosci Res 61:564–569
**ao XQ, Zhang HY, Tang XC (2002) Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation. J Neurosci Res 67:30–36
**ong Z-Q, Tang X-C (1995) Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats. Pharmacol Biochem Behav 51:415–419
**ong ZQ, Cheng DH, Tang XC (1998) Effects of huperzine A on nucleus basalis magnocellularis lesion-induced spatial working memory deficit. Zhongguo yao li xue bao 19:128–132
Xu SS, Gao ZX, Weng Z et al (1995) Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer’s disease. Acta Pharmacol Sin 16:391–395
Xu SS, Cai ZY, Qu ZW et al (1999) Huperzine-A in capsules and tablets for treating patients with Alzheimer disease. Acta Pharmacol Sin 20:486–490
Yan XF, Lu WH, Lou WJ, Tang XC (1987) Effects of huperzine A and B on skeletal muscle and the electroencephalogram. Zhongguo yao li xue bao 8:117–123
Yang Y-B, Yang X-Q, Xu Y-Q et al (2008) A New Flavone Glycoside from Huperzia serrata. Chin J Nat Med 6:408–410
Yang Y-F, Qu S-J, **ao K et al (2010) Lycopodium alkaloids from Huperzia serrata. J Asian Nat Prod Res 12:1005–1009
Ye JW, Cai JX, Wang LM, Tang XC (1999) Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment. J Pharmacol Exp Ther 288:814–819
Ye JC, Zeng S, Zheng GL, Chen GS (2008) Pharmacokinetics of huperzine A after transdermal and oral administration in beagle dogs. Int J Pharm 356:187–192
Yu D, Thakor DK, Han I et al (2013) Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A. Proc Natl Acad Sci USA 110:E746–E755
Yuan J, Zhou X, Wang S et al (2012) Advances in studies on chemical constituents of Huperzia serrata and their pharmacological effects. Chinese Tradit Herb Drugs 43:399–407
Yue P, Tao T, Zhao Y et al (2007) Huperzine A in rat plasma and CSF following intranasal administration. Int J Pharm 337:127–132
Zangara A (2003) The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer’s disease. Pharmacol Biochem Behav 75:675–686
Zhang H-Y (2012) New insights into huperzine A for the treatment of Alzheimer’s disease. Acta Pharmacol Sin 33:1170–1175
Zhang RW, Tang XC, Han YY et al (1991) Drug evaluation of huperzine A in the treatment of senile memory disorders. Acta Pharmacol Sin 12:250–252
Zhang Z, Wang X, Chen Q et al (2002) Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi 82:941–944
Zhang HY, Yan H, Tang XC (2004) Huperzine A enhances the level of secretory amyloid precursor protein and protein kinase C-alpha in intracerebroventricular beta-amyloid-(1–40) infused rats and human embryonic kidney 293 Swedish mutant cells. Neurosci Lett 360:21–24
Zhang Z-J, Tong Y, Wang X-Y et al (2007) Huperzine A as add-on therapy in patients with treatment-resistant schizophrenia: an open-labeled trial. Schizophr Res 92:273–275
Zhang S, Wang G, Luo G et al (2008) Effects of huperzine A on cognitive function of rats recovering from general anesthesia. Nan Fang Yi Ke Da Xue Xue Bao 28:225–227
Zhang L, Cao H, Wen J, Xu M (2009) Green tea polyphenol (−)-epigallocatechin-3-gallate enhances the inhibitory effect of huperzine A on acetylcholinesterase by increasing the affinity with serum albumin. Nutr Neurosci 12:142–148
Zhang C, Kwan P, Zuo Z, Baum L (2012) The transport of antiepileptic drugs by P-glycoprotein. Adv Drug Deliv Rev 64:930–942
Zhang L, Song Y, Lu C et al (2013) The effects of huperzine A on gastrointestinal acetylcholinesterase activity and motility after single and multiple dosing in mice. Exp Ther Med 5:793–796
Zhao HW, Li XY (1999) Ginkgolide A, B, and huperzine A inhibit nitric oxide production from rat C6 and human BT325 glioma cells. Acta Pharmacol Sin 20:941–943
Zhao H-W, Li X-Y (2002) Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity. Int Immunopharmacol 2:1551–1556
Zhao Q, Tang XC (2002) Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine. Eur J Pharmacol 455:101–107
Zhao Y, Yue P, Tao T, Chen Q (2007) Drug brain distribution following intranasal administration of huperzine A in situ gel in rats. Acta Pharmacol Sin 28:273–278
Zheng CY, Zhang HY, Tang XC (2008) Huperzine A attenuates mitochondrial dysfunction after middle cerebral artery occlusion in rats. J Neurosci Res 86:2432–2440
Zhou J, Tang XC (2002) Huperzine A attenuates apoptosis and mitochondria-dependent caspase-3 in rat cortical neurons. FEBS Lett 526:21–25
Zhou GC, Zhu DY (2000) Synthesis of 5-substituted analogues of huperzine A. Bioorg Med Chem Lett 10:2055–2057
Zhou J, Fu Y, Tang XC (2001a) Huperzine A and donepezil protect rat pheochromocytoma cells against oxygen-glucose deprivation. Neurosci Lett 306:53–56
Zhou J, Zhang HY, Tang XC (2001b) Huperzine A attenuates cognitive deficits and hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci Lett 313:137–140
Zhou H, Li Y-S, Tong X-T et al (2004) Serratane-type triterpenoids from Huperzia serrata. Nat Prod Res 18:453–459
Zhu X-Z (1991) Development of natural products as drugs acting on central nervous system. Mem Inst Oswaldo Cruz 86:173–175
Zhu XD, Giacobini E (1995) Second generation cholinesterase inhibitors: effect of (L)-huperzine-A on cortical biogenic amines. J Neurosci Res 41:828–835
Zhu D-Y, Jiang S-H, Huang M-F et al (1994) Huperserratinine from Huperzia serrata. Phytochemistry 36:1069–1072
Zhu XZ, Li X-Y, Liu J (2004) Recent pharmacological studies on natural products in China. Eur J Pharmacol 500:221–230
Zimmermann GR, Lehár J, Keith CT (2007) Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 12:34–42
Acknowledgments
The authors thank the support of Fundação para a Ciência e a Tecnologia (FCT, Portugal) through the fellowship SFHR/BD/84936/2012, involving the POPH (Programa Operacional Potencial Humano) which is co-funded by FSE (Fundo Social Europeu), and through the strategic project Pest-OE/SAU/UI0709/2014.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ferreira, A., Rodrigues, M., Fortuna, A. et al. Huperzine A from Huperzia serrata: a review of its sources, chemistry, pharmacology and toxicology. Phytochem Rev 15, 51–85 (2016). https://doi.org/10.1007/s11101-014-9384-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11101-014-9384-y